# Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy

> **NCT01406769** · PHASE2 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 120 (estimated)

## Conditions studied

- Lymphedema
- Perioperative/Postoperative Complications
- Stage IA Vulvar Cancer AJCC v7
- Stage IB Vulvar Cancer AJCC v7
- Stage II Vulvar Cancer AJCC v7
- Stage IIIA Vulvar Cancer AJCC v7
- Stage IIIB Vulvar Cancer AJCC v7
- Stage IIIC Vulvar Cancer AJCC v7
- Stage IVA Vulvar Cancer AJCC v7
- Stage IVB Vulvar Cancer AJCC v6 and v7

## Interventions

- **PROCEDURE:** Bioelectric Impedance Analysis
- **PROCEDURE:** Lymphadenectomy
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT01406769
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-16
- **Primary completion:** 2020-04-10
- **Final completion:** 2020-04-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406769, "Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01406769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*